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ABSTRACT 
 
Response to Incorporation of Supplemental Gonadotropins for Donor and Recipient 
Protocols in Commercial Bovine Embryo Transfer.  (May 2012) 
Kelley Christine Chiles, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. David Forrest 
 
 Superovulation of donor cows, embryo transfer, and estrus synchronization of 
recipients are widely used technologies in the purebred cattle industry.  Progress 
continues to be made to achieve efficient and economic use of these technologies. 
 The first retrospective study was conducted to compare embryo production 
between a stimulation protocol using only Folltropin
® 
as the gonadotropin, and a 
stimulation protocol using Folltropin
® 
and Pluset
®
.  Beefmaster donor cows (n=12) were 
stimulated using both protocols over two stimulated cycles, one protocol each cycle.  
Both protocols used the same synchronization protocol with only the gonadatropin 
injections differing.  The control protocol (Folltropin
®
 protocol) consisted of seven 
Folltropin
® 
injections over the course of 3.5 days.  The treatment protocol (Folltropin
®
 + 
Pluset
®
 protocol) consisted of four Folltropin
®
 injections followed by three Pluset
®
 
injections over the course of 3.5 days.  The mean numbers of viable embryos did not 
differ between treatments (P>0.01) and were 9.33 and 6.58 for the control and treatment 
protocols, respectively.  The proportion of viable embryos to total ova for each protocol 
was 0.49 and 0.48 for the control and treatment protocols, respectively (P > 0.10).  No 
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significant difference on embryo production was observed between the control and 
treatment protocols. 
 The second retrospective study was performed to compare pregnancy rates after 
embryo transfer between Beefmaster recipients who received eCG during 
synchronization and recipients who did not receive eCG during synchronization.  Due to 
the conditions of this study, statistical analysis could not be performed.  Pregnancy rates 
are reported, but they are not statistically significant.  Recipients in the control group 
(n=332) were synchronized with a protocol using a CIDR insert for seven days, a 
progesterone estradiol injection at the time of CIDR insertion, a prostaglandin (PG) 
injection at CIDR removal, and an estradiol injection the day after CIDR removal.  
Recipients in the treatment group (n=142) were synchronized using the same 
synchronization protocol as the control group, except eCG was administered five days 
after CIDR insertion.  Pregnancy rates were 44.88 and 38.73 for the control and 
treatment groups, respectively.  The addition of eCG to the synchronization protocol did 
not appear to be either beneficial or detrimental to pregnancy rate under the conditions 
of this study.      
 In summary, the addition of Pluset
® 
to the stimulation protocol for donors was 
not detrimental to embryo production.  The estrus synchronization protocol with eCG for 
recipients did not appear to be beneficial; however, a controlled studies are still 
warranted to further investigate the potential effects of recipient age, parity, body 
condition score, or breed effect on response to eCG.  
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CHAPTER I 
INTRODUCTION AND REVIEW OF LITERATURE 
 
Introduction 
  Superovulation, embryo transfer, and estrus synchronization are widely used 
technologies in the purebred cattle industry.  Continued progress towards the 
optimization of embryo yield and quality, and improvements in pregnancy rates are 
required for the efficient and economical use of these technologies.  Adequate hormonal 
therapies that support a large number of ovulatory follicles to develop are critical for 
successful superovulation procedures in both cows and heifers.  However, many breeds 
of cattle, in particular Bos indicus-influenced breeds, may show varied responsiveness to 
the hormones used for superovulation (Bo et al., 2010).  Many synchronization protocols 
exist for recipient cows, but some protocols may be more beneficial when used in Bos 
indicus-influenced recipients than others (Nasser et al., 2004, Baruselli et al., 2010).   
 
Induction of Superovulation 
 Cattle are polyestrus, with an estrous cycle (21 d on average) occurring regularly 
throughout the year.  The bovine estrous cycle is broken into two phases consisting of 
the follicular phase (20% of the estrous cycle) and the luteal phase (80% of the estrous 
 
___________ 
This thesis follows the style of Journal of Animal Science. 
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cycle).  The follicular phase starts after luteolysis, when progesterone is low, and ends at 
ovulation.  During the follicular phase, gonadotropins are secreted causing continued 
follicular growth and increased estrogen production from the follicle.  The luteal phase 
starts after ovulation, continues through the development of the corpus luteum (CL), and 
ends after luteolysis.  During the luteal phase, the CL develops and secretes increasing 
amounts of progesterone, with the peak of progesterone secretion occurring after the CL 
becomes fully functional.    Follicular waves will occur throughout the estrous cycle with 
luteinization of the follicle and ovulation occurring only after luteolysis when 
progesterone is low (reviewed by Senger, 2003).  A follicular wave is characterized by a 
synchronous growth of a cohort of small follicles, and is preceded by a rise in plasma 
FSH 1 to 2 d before emergence (Adams, 1994).  Cattle have been reported to exhibit 
two-wave and three-wave estrous cycles.  After selection of the dominant follicle, the 
subordinate follicles undergo atresia and new follicular waves are prevented by the 
suppression of FSH caused by the dominant follicle (Adams, 1994).  The induction of 
superovulation, and continued growth of multiple follicles, in cattle can be achieved with 
administration of exogenous gonadotropins, usually follicle stimulating hormone (FSH).  
Gonadotropin treatment can be initiated on the first follicular wave emergence with no 
difference in response observed when compared to gonadotropin treatment initiated on 
the second follicular wave (Adams et al., 1994).  Adams et al. (1994) also noted that 
treatment with gonadotropins, particularly FSH, early in follicular wave emergence is 
more important than which wave (first or second) the treatment is initiated.  The 
ovulatory response is increased when FSH is administered beginning the day before, or 
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the day of, follicular wave emergence (Bo et al., 1995).  The purity of the FSH 
preparation administered is also important.  Numerous studies have reported a lower 
percentage of transferrable embryos are produced when the LH content of an FSH 
preparation is increased compared to a more purified FSH preparation (reviewed by 
Mapletoft et al., 2002).   
FSH is typically administered twice-daily over 4 to 5 d in decreasing doses to 
stimulate follicular development in cattle (reviewed by Bo et al., 2010).  Other protocols 
involving single injections and once-daily injections of FSH have also been used; with 
varying results.  A single subcutaneous injection of Folltropin
®
 yielded a response 
comparable to twice-daily intramuscular injections of Folltropin
®
 (Bo et al., 1991, Bo et 
al., 1994, Schallenberger et al., 1994) in beef cows with a good body condition score, but 
not in dairy cows (Lovie et al., 1994).  Lovie et al. (1994) reported that dividing 
Folltropin
®
 into two subcutaneous doses can improve superstimulatory response 
compared to a single subcutaneous dose, but multiple intramuscular injections still yield 
the best superstimulatory responses.  Single subcutaneous doses of Folltropin
®
 have 
been reported to have inconsistent superstimulatory responses among different breeds 
and body condition scores, which can be attributed to varying amounts of subcutaneous 
fat depending on breed and parity (Lovie et al., 1994, Bo et al., 1994).  The single 
subcutaneous injection of Folltropin
® 
is not used in the commercial embryo transfer 
industry today due to the inconsistent superstimulatory response generated.  Other 
protocols using once-daily injections of FSH for 4 days have reported superstimulatory 
responses and transferable embryo results similar to the more traditional twice-daily 
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injections (Kanitz et al., 2002).  However, others have found twice-daily injections to be 
superior to once-daily injections (Walsh et al., 1993).  A twice-daily injection of FSH for 
4 days is the most common stimulatory protocol currently used in the commercial ET 
industry (Bo et al., 2010).  To optimize superstimulatory response in cattle, it is 
necessary to initiate exogenous FSH administration the day before (or the day of) 
follicular wave emergence, and continue to administer FSH twice-daily during the 
stimulation protocol. 
 
Gonadotropin-Dependent Follicular Growth 
 Antral follicles become dependent on FSH  at approximately 4 mm, and require 
elevated FSH levels for their continued growth and steroid production (reviewed by 
Mihm and Bleach, 2003).  Mihm and Bleach (2003) explained that these follicles will 
continue to produce estradiol and inhibin which will reduce FSH secretion and results in 
selection of the dominant follicle.  After selection, the dominant follicle switches from 
FSH dependency to LH dependency, requiring LH for continued growth and 
steroidogenesis (Mihm and Bleach, 2003).  
 Gene expression for FSH receptors and LH receptors has been studied during 
development of the dominant follicle.  During the anovulatory follicular wave in cattle, 
as the dominant follicle grows its dependence on FSH  decreases as its dependence on 
LH increases (Mihm et al., 2006).  Mihm et al. (2006) found mRNA expression for the 
FSH receptor in granulosa cells decreased as mRNA expression for the LH receptor 
increased during dominant follicle growth.  The authors suggested this provides 
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molecular evidence that the dominant follicle does not depend completely on FSH and 
LH plays a role for continued growth of the dominant follicle as serum concentrations of 
FSH decrease while pulsatile frequency of LH secretion increases.  In Nelore cows, an 
increase in LH receptor gene expression was observed in granulosa cells, but not in theca 
cells, as follicle diameter increased (Simões et al., 2011).  Simões et al. (2011) reported a 
high ovulation rate (90%) in follicles larger than 10 mm when exogenous LH was 
administered.  The high ovulatory rate was attributed to the increased amount of LH 
receptor gene expression in the granulosa cells of follicles greater than 10 mm. 
 
Effect of Stimulation Protocols on the Preovulatory LH Surge and Oocyte 
Maturation in Cattle 
 A sufficient preovulatory surge of LH is necessary to cause ovulation in 
dominant follicles that have acquired the capacity to luteinize in response to LH.  
Without an adequate preovulatory LH surge, ovulation of capable follicles will not 
occur.  This is important in superovulation of donor cows because ovulation of the 
stimulated follicles needs to occur to allow for fertilization of the ova and the subsequent 
embryo collection.  The mean interval from the induction of luteolysis (first PGF2α 
injection) to the preovulatory LH surge when cows were stimulated with FSH has been 
reported to be 46.5 ± 4.4 h with ovulations starting between 62 to 68 h after PGF2α, and 
an interval of 1.2 to 12 h from the first to last ovulations (reviewed by Kanitz et al., 
2002).  The interval, up to 12 h, between the first to last ovulations indicates the need for 
multiple inseminations to maximize fertilization rates (reviewed by Kanitz et al., 2002).  
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Ovarian stimulation in Bos indicus females has been shown to decrease the intervals 
from CIDR removal to the preovulatory LH surge.  When estrous synchronization was 
performed, Nelore cows had a preovulatory LH surge 46.7 ± 4.9 h after CIDR removal 
with ovulation beginning 25.6 ± 7.4 h after the preovulatory surge (Monteiro et al., 
2009).  These same Nelore cows were then stimulated with Folltropin
®
 and had a 
preovulatory LH surge 34.6 ± 1.6 h after CIDR removal with ovulation occurring 24.9 ± 
1.6 h after the LH surge.  Monteiro et al. (2009) suggested that the 12 h difference in the 
interval from CIDR removal to the preovulatory LH surge may be due to a higher level 
of plasma estradiol as a result of the increase in follicles from the superovulatory 
treatment.    
 The follicular fluid in unstimulated cattle before the LH peak contains a high 
concentration of estradiol (E2); this concentration decreases within the first 10-12 h after 
the peak of the LH surge and remains low until approximately 24 h after the peak of the 
LH surge when ovulation occurs (Dieleman et al., 1983, Hyttel et al., 1991).  The 
progesterone (P4) concentration in the follicular fluid follows a different pattern than E2.  
Before the LH peak P4 is low, rises during the surge, and decreases 4-6 h after the peak; 
a dramatic increase in P4 occurs 20-24 h after the peak (Dieleman et al., 1983, Hyttel et 
al., 1991).  Within 4-8 h after the LH peak, meiosis resumes (characterized by germinal 
vesicle breakdown).  Metaphase I is observed in oocytes within 19 h after the LH peak, 
with most oocytes reaching metaphase II 19-25 h after the LH peak (Hyttel et al., 1991).  
In superovulated cattle, follicular steroidogenesis was similar to unstimulated cattle, but 
there was more variation in the rate of oocyte maturation in superovulated cattle when 
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compared to their unstimulated counterparts (Dieleman et al., 1983, Kruip et al., 1983, 
Hyttel et al., 1991).  Hyttel et al. (1991) found that superovulated animals that lacked the 
LH surge experienced a large proportion of premature oocyte maturation which was 
attributed to the LH content of the eCG and FSH preparations.  An increase in the 
frequency of oocytes that began maturation but were arrested in diakinesis or metaphase 
I was also observed in stimulated cattle (Hyttel et al., 1991).  While ovarian stimulation 
does not appear to have an effect on follicular steroidogenesis, it does appear to have an 
impact on oocyte maturation. 
 
Manipulating Follicular Waves with Estradiol 
 Estradiol has been used in many synchronization programs for fixed-time AI 
(FTAI), fixed-time embryo transfer (FTET), and even in synchronization programs for 
superovulated donors.  The common forms of estradiol used include estradiol-17β (E-
17β), estradiol benzoate (EB), and estradiol valerate (EV).  Estradiol is used to induce 
the emergence of a new follicular wave and to synchronize ovulation (Martínez et al., 
2005, Martínez et al., 2007).  Embryo quality can also be improved when follicular wave 
emergence is induced using hormones, such as progesterone and estradiol, or follicle 
ablation (Bo et al., 1995).   
The administration of E-17β has a suppressive effect on FSH release for about 48 
h, which causes the FSH-dependent follicles to undergo atresia (Martínez et al., 2005, 
Martínez et al., 2007, Bo et al., 1995).  Plasma FSH concentration begins to rise above 
pretreatment levels approximately 60 h after E-17β treatment, and a new follicular wave 
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emerges approximately 1 d after the increase in plasma FSH above pretreatment levels 
(Martínez et al., 2005).  Administration of exogenous estradiol has also been shown to 
have an atretic effect on follicles (reviewed by Dierschke et al., 1994).  Increased 
androgen production, reduced progesterone and estrogen production, a reduced number 
of granulosa cells, and degenerated oocytes (all markers of atresia) have all been 
observed in follicles when exogenous estradiol has been administered; these markers of 
atresia were still observed even when FSH and LH were administered in conjunction 
with estradiol.  Estradiol has been shown to have a biphasic effect on LH secretion.  
Initially, a surge of LH occurring approximately 24 h after E-17β administration is 
observed, followed by a decrease in LH secretion and a return to nadir 72 h after 
treatment (Martínez et al., 2007).  The LH surge could be attributed to the inability of 
progesterone, administered in conjunction with E-17β, to effectively block the release of 
LH during the high concentration of plasma estradiol which occurs within 2 h of E-17β 
administration.  The suppression of LH can be attributed to the synergistic effects of 
progesterone, which decreases LH pulse frequency; and estradiol, which decreases LH 
pulse amplitude (Price et al., 1999).  Gonadotropins must be suppressed for at least 24 h 
for complete dominant follicle regression to occur and a new follicular wave to emerge 
(Bo et al., 1995).   
The interval from hormone administration to new follicular wave emergence 
depends on the form of estradiol used.  Following administration of 5 mg of E-17β, EB, 
or EV, a new follicular wave emerges on average 4.3 d later (Bo et al., 1995), 5.4 d later 
(Bó et al., 1998), and 5.7 d later (Mapletoft et al., 1999), respectively.  When just 1 mg 
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of EB is used, a new follicular wave will emerge at a time similar to that of E-17β 
because the suppression of FSH is shorter and more similar to E-17β (Martínez et al., 
2005).  When GnRH is administered a new follicular wave emerges on average 2 d later, 
but the interval is more variable than the interval following estradiol/progesterone 
administration (Martinez et al., 2000).  The variability in interval to follicular wave 
emergence in response to GnRH is related to the stage of the dominant follicle at the 
time of GnRH administration.  An emergence of a new follicular wave does not occur if 
ovulation of the dominant follicle does not occur after  treatment with GnRH (Martinez 
et al., 1999).  Follicles must reach a certain size to be responsive to the GnRH treatment.  
Martinez et al. (1999) reported that ovulation in response to GnRH occurred in all 
heifers where the largest follicle was 9-10 mm in diameter.   
A CIDR, or other progesterone releasing device, is usually incorporated in these 
synchronization programs, and progesterone is typically injected along with the estradiol 
at the beginning of the protocol (Martínez et al., 2005, Martínez et al., 2007).  A second 
injection of estradiol can also be administered after CIDR removal to synchronize 
ovulation which is beneficial in fixed-time AI and fixed-time ET.  Administering 
estradiol 24 h after CIDR removal has been reported as the optimal time to prevent early 
ovulations, and to allow the dominant follicle time to reach an adequate size to ensure 
fertility (Martínez et al., 2007).  
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Estrous Cycles: Bos indicus and Bos taurus Cattle 
 Many differences in the estrous cycles between Bos indicus and Bos taurus cattle 
have been reported, while some more recent studies have shown them to be more similar 
than originally thought.  The number of small follicles present at the beginning of a 
follicular wave has been reported to be higher in Brahman cows (39 ± 4) when compared 
to Angus cows (21 ± 4), and a higher number of medium and large follicles was also 
observed in Brahman cows when compared to Angus cows (Alvarez et al., 2000).  The 
duration of standing estrus has been reported to be shorter in Nelore cows (12.9 h) and 
Nelore X Angus crosses (12.4 h) when compared to Angus cows (16.3 h), but the timing 
of ovulation from the onset of estrus has recently been reported to not differ significantly 
from Bos taurus and Bos indicus breeds (reviewed by Bó et al., 2003). Previous studies 
have reported that the interval from the onset of estrus to ovulation was shorter in 
Brahman females compared to their Bos taurus (Hereford) counterparts, but the interval 
from the preovulatory LH surge to ovulation did differ significantly among Brahman and 
Hereford females (reviewed by Randel, 1994).  Bo et al. (2003) suggest the use of Heat-
Watch™ for estrus detection, and ultrasonography, could explain why recent findings on 
the interval from the onset of estrus to ovulation differ from previous findings.  The 
maximum diameter of the dominant follicle and the CL appears to be smaller in Bos 
indicus females than Bos taurus females (reviewed by Bó et al., 2003, Sartori and 
Barros, 2011).  In a study conducted by Alvarez et al. (2000), the CL diameter was 
reported to be 10% greater in Brahman cows than in Angus cows.  The effect of heat 
stress on the Angus cows due to season and climate may have contributed to this 
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inconsistency, since the experiment was conducted during the summer (July-August) in 
Florida.  The growth rate of the dominant follicle between Bos indicus cows and Bos 
taurus cows are inversely related and related to season.  Bos indicus cows have a slower 
dominant follicle growth rate in the fall (1.1 mm/day) compared to the spring (1.5 
mm/day), and Bos taurus cows show a faster dominant follicle growth rate in the fall 
(1.6 mm/day) than in the spring (1.4 mm/day) (Bó et al., 2003).  Many of the same 
synchronization protocols are used between Bos indicus and Bos taurus females with 
success, despite the differences in the duration of standing estrus and follicular growth 
rate.   
 
Equine Chorionic Gonadotropin 
 The hormone, equine chorionic gonadotropin (eCG), is produced in pregnant 
mares by the endometrial cups that are present on the embryonic girdle (Hoppen, 1994). 
The placental gonadotropin consists of an α-subunit (96 amino acids) and a β-subunit 
(149 amino acids); the β-subunit of eCG is identical to the β-subunit of the equine LH 
(reviewed by Murphy and Martinuk, 1991).  The secretion of eCG reaches its peak 
between day 60 and day 80 of pregnancy (Hoppen, 1994).  The β-subunit of eCG  
determines the LH and FSH activity, and also the level of FSH activity that this hormone 
produces in cattle (Chopineau et al., 1997).  In mammals other than the horse, eCG binds 
to both FSH and LH receptors and produces biological responses similar to both of those 
hormones (reviewed by Murphy and Martinuk, 1991).  The β-subunit of eCG must be 
associated with the equine α-subunit  to possess the FSH and LH activities (Chopineau et 
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al., 1997).  Equine CG has a long half-life which can be attributed to its heavy 
glycoslyation and sialic acid linkages (reviewed by Murphy and Martinuk, 1991).  A 
biphasic model of  eCG clearance has been suggested in cattle; with the first phase (45.6 
h half-life) consisting of the rapid removal from circulation, and the second phase (121 h 
half-life) consisting of the metabolism and excretion of eCG from the extravascular 
compartments (reviewed by Murphy and Martinuk, 1991).    
An increase in StAR (steroidogenic acute regulatory protein) mRNA levels was 
found in heifers that were treated with eCG compared to StAR mRNA levels found in 
heifers treated with FSH (Soumano and Price, 1997).  This increase in StAR mRNA was 
observed in medium and large follicles during the follicular phase of the stimulated 
estrous cycle (Soumano and Price, 1997).   StAR mRNA levels  correlate with the active 
StAR protein (Clark, 1995), so increased mRNA levels should indicate increased StAR 
protein production.  It has been suggested that StAR protein is the rate limiting step in 
steroidogenesis because it is the protein responsible for transporting cholesterol into the 
mitochondria where it is then converted into pregnenolone, the precursor for 
progesterone (Stocco, 1997).   Therefore, increased StAR protein should result in 
increased steroidogenesis, including the production of estradiol and progesterone.  The 
increase in StAR protein seen in eCG-treated animals could help to explain the increased 
follicular progesterone and estradiol secretion that has been found in eCG-treated 
animals when compared to FSH-treated animals (Soumano and Price, 1997). 
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Use of eCG in Protocols for Estrus Synchronization  
 Many protocols are used to synchronize estrus and the timing of ovulation in 
recipient cows with the intention of preparing the uterus to receive an embryo.  Fixed-
time AI/ET protocols work well for this purpose, since estrus detection ability among 
farms is variable.  Bos indicus cattle reportedly have a smaller diameter of the dominant 
follicle and the CL, and also less progesterone content in their CL (Bó et al., 2003), 
which is why eCG (because of its long-lasting FSH and LH properties) has been added 
to many synchronization protocols involving Bos indicus influenced breeds.  It has been 
shown the addition of 400 IU of eCG at the time of progesterone releasing intravaginal 
device (PRID) removal along with progesterone/estradiol treatment at the time the PRID 
is inserted, can increase the pregnancy rates of Bos indicus heifers when fixed timed 
artificial insemination (FTAI) is performed (Bó et al., 2003).  An increase pregnancy 
rate, from eCG administration, was also more evident when cows had small follicles 
instead of a CL or medium to large follicles at the beginning of synchronization (Bó et 
al., 2003)   Another study using FTAI in beef cows showed that the addition of eCG 
improved the pregnancy rate of primiparous but not multiparous cows, and that eCG 
may be more beneficial in cows with lower body condition scores (Small et al., 2009).  
In a FTAI comparison between FSH and eCG administration on the  day of PRID 
removal, eCG was found to increase ovulation rate (95.5%) and pregnancy rate (66.7%) 
significantly in lower BCS anestrous cows while the FSH-treated cows received no 
benefit in ovulation rate (56.4%) and pregnancy rate (25.5%) compared to controls 
(Sales et al., 2011).  There was also a significant increase in follicular growth in the 
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eCG-treated group (1.4 mm/day) when compared to the FSH (0.90 mm/day) and control 
group (0.95 mm/day).  Sales et al. (2011) suggested the higher follicular growth rate 
seen in the eCG-treated cows can be explained by the higher LH activity of eCG 
compared to purified FSH, and the increased follicular growth rate may have led to the 
higher ovulation rate in cows treated with eCG.   
Although the fertility of the oocyte that is ovulated is not a major concern in 
recipient cows, the resulting CL is.  Previous studies using eCG when compared to FSH 
showed an increase in progesterone concentrations (Chagas e Silva et al., 2002), 
indicating a luteotrophic effect of eCG which may improve pregnancy rate in recipients 
as well.  Several studies in Bos indicus-influenced recipient cows have shown several 
factors that correlate with pregnancy rate, including plasma progesterone concentration 
and CL diameter and number.  Plasma progesterone concentration was observed to 
positively correlate with CL size and number in Bos indicus-influenced recipients, and as 
a result a higher pregnancy rate (reviewed by Baruselli et al., 2010).  Although, the 
above correlation was not seen in Bos taurus recipient cows, it was found that pregnancy 
rate in Bos indicus recipients was significantly higher in recipient cows that had a 
plasma progesterone concentration greater than 3 ng mL
-1
 when compared to the 
pregnancy rate of recipient cows with a non-functional CL and a plasma progesterone 
concentration less than 1 ng mL
-1 
(reviewed by Baruselli et al., 2010).  Area of the CL 
was positively correlated with plasma progesterone concentration, and  pregnancy rate 
was higher for heifers with a CL area larger than 2 cm
2
 compared to a CL area smaller 
than 1.5 cm
2
 (reviewed by Baruselli et al., 2010).  Contradictory results from another 
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study reported no correlation between plasma progesterone concentration and 
pregnancy/conception rates in Bos taurus X Bos indicus recipients (Siqueira et al., 
2009). Siqueira et al. (2009) also reported no correlation between CL area and pregnancy 
rate in recipients.   
Many studies were conducted to investigate the effect of the dose of eCG 
administered, and the day of eCG administration(reviewed by Baruselli et al., 2010).  
Increasing doses of eCG (400, 500, and 600 IU) did not affect pregnancy rate; therefore, 
400 IU of eCG was determined to be the optimal dose, since increasing the dose resulted 
in no added benefit.  The day of eCG administration (day 5 and day 8) did affect 
pregnancy rate.  The administration of 400 IU of eCG on d 5 (progesterone releasing 
device insertion on d 0) was shown to increase CL area and plasma progesterone 
concentration during the luteal phase (reviewed by Baruselli et al., 2010).  The increase 
in CL area could be a result of increased size of the dominant follicle at luteinization 
from the gonadotropic effect of eCG, and the increased progesterone concentration 
during the luteal phase could be a result of the long-lasting LH activity of eCG.  As a 
result, pregnancy rate increased in Bos indicus-influenced recipients.  This is in 
agreement with a previous study in which administration of 400 IU of eCG to Bos 
indicus X Bos taurus recipients on day 5 resulted in a higher number of CL’s, higher 
plasma progesterone concentration, and higher pregnancy rate when compared to 
administration of eCG on day 8 (Nasser et al., 2004).  Nasser et al. (2004) noted that 
eCG administered on day 5 would stimulate multiple follicles, since the follicular wave 
is at an early stage of dominance, while administration on day 8 may only just stimulate 
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the dominant follicle.  The use of eCG is the most effective when used in Bos indicus-
influenced recipients, recipients that are primiparous, or recipients that are under 
nutritional stress. 
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CHAPTER II 
SUPEROVULATION OF BEEF COWS WITH FOLLTROPIN
®
 AND PLUSET
® 
 
Introduction 
 Folltropin
®
 is a common porcine pituitary derived FSH preparation used in the 
superovulation of donor cows, but other FSH preparations can be used as well.  Pluset
®
 
is one of these porcine pituitary derived preparations, having a 1:1 FSH:LH ratio (Kelly 
et al., 1995). The ratio of FSH:LH for Folltropin
®
, determined by radioreceptor assay, is 
49:1 (Henderson et al., 1990).  An increased LH content in FSH preparations has been 
found to be detrimental to embryo production, resulting in a decreased percentage of 
transferrable embryos (reviewed by Mapletoft et al., 2002).  Others have observed that 
stimulated cattle show an increase in the proportion of oocytes that have undergone 
premature oocyte maturation which they attribute to the LH content in FSH preparations 
(Hyttel et al., 1991).  This observation could explain the decrease in percentage of 
transferrable embryos that typically occur when FSH preparations containing a higher 
LH content are used for superstimulation.   
 A single gonadotropin preparation is typically used during each stimulated cycle 
in most research conducted on the use of various gonadotropin preparations for the 
induction of superovulation.  There is a paucity of information regarding the use of 
multiple FSH preparations during a single stimulated cycle in superovulated donors.    
 In this study, the objective was to compare embryo production between a 
Folltropin
®
 protocol and a Folltropin
®
 + Pluset
®
 protocol for superovulation of donor 
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cows.  It was hypothesized that the higher LH content in Pluset
®
 would not have a 
detrimental effect on embryo production since it was only administered near the end of 
the gonadotropin stimulation protocol.  The higher LH content in Pluset
®
 should 
improve follicular maturation and improve oocyte quality, therefore, improving embryo 
yield.  Retrospective analysis was conducted on data provided by a private embryo 
transfer company (OvaGenix, LP, Bryan, TX, USA) to accomplish the objective. 
 
Materials and Methods 
 The data for this study was obtained from embryo collection records of work 
performed by a private embryo transfer company, OvaGenix, LP.     
 The objective of this study was to compare the effects of two different hormone 
preparations and protocols on embryo production.  Each multiparous, Beefmaster donor 
cow from El Lucero, located in Mexico, was stimulated using both protocols in a 
switchback arrangement.    Each protocol was initiated without regard to the stage of the 
estrous cycle.  The control group (Figure 1) was administered a total of seven 
Folltropin
®
-V (Bioniche Animal Health, Belleville, Ontario, Canada) injections (im) at 
12-h intervals to induce superstimulation. The treatment group (Figure 2) was 
administered a total of four Folltropin
®
-V injections followed by three Pluset
®
 (Minitube 
of America, Inc., Verona, WI, USA) injections (im).  A total of 12 donor cows were 
included in this study.  Six of the donors were stimulated using the Folltropin
®
-V 
protocol for their first stimulated cycle, and then stimulated using the Folltropin
®
-V + 
Pluset
®
 protocol for their second stimulated cycle.   
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Figure 1. Stimulation protocol for control group (Folltropin
®
). 
 
 
 
 
 
 
 
 
 
 
Figure 2. Stimulation protocol for treatment group (Folltropin
®
 + Pluset
®
). 
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The remaining six donors were stimulated with the Folltropin
®
-V + Pluset
®
 protocol on 
their first stimulated cycle, and then they were stimulated using the Folltropin
®
-V 
protocol for their second stimulated cycle.   
 Both groups of donors were administered a CIDR
®
 (Pfizer Animal Health, 
Kalamazoo, MI, USA) and an injection (2 mL, im), containing 25 mg/mL of 
progesterone and 1.25 mg/mL of estradiol (Med Shop Total Care Pharmacy, Inc., 
Longview, TX, USA), on day 0.  FSH injections were administered twice-daily in 
decreasing dosages beginning on the morning of day 4.  The total amount of Folltropin
®
-
V administered to donors in the control group ranged from 120 mg to 232 mg NIH-FSH-
P1.  The total amount of Folltropin
®
-V administered to the donors in the treatment group 
ranged from 104 mg to 152 mg NIH-FSH-P1.  The amount of Pluset
®
 administered was 
the same for all donors.  The volume of each consecutive Pluset
®
 injection was 1.0 mL, 
0.8 mL, and 0.6 mL (im), respectively, for a cumulative dose of 120 IU of FSH and 120 
IU of LH.  The total amount of FSH product each donor received was determined by the 
ET practitioner with consideration for age, parity, weight, and previous embryo 
collection history.  Within each donor cow, the amount of FSH administered varied 
between stimulated cycles.  A 2.5 mL injection (im) of Ciclase
®
 (Syntex S.A., Buenos 
Aires, Argentina), a prostaglandin (PGF2α) analogue containing 250 µg/mL of 
cloprostenol, was administered along with the 5th and 6th FSH injection.  The CIDR
®
 
was removed on day 7 and cows were observed for estrus.   
 The donors were artificially inseminated (AI) beginning 12 to 16 h after estrus 
with two units of semen; 20 to 24 h post-estrus with one unit of semen; and 30 to 36 h 
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post-estrus with one unit if the donor was still in standing estrus at the time of the second 
insemination.  Multiple sires were used.  In conjunction with the first AI, GnRH (100 
µg, 2 mL Cystorelin
®
; Merial LLC, Duluth, GA, USA) was administered (im).     
 Embryos were collected between 7 and 7.5 d post-estrus.  The donors were 
collected nonsurgically using an 18 or 20 gauge Foley catheter (Bardia, Covington, GA, 
USA) which was inserted through the cervix and the balloon cuff was inflated.  The 
Foley catheter was then connect to an EZ way filter with Y junction tubing (PETS, 
Canton, TX, USA).  The media used for embryo collection was Lactated Ringer’s 
(Hospira Inc., Lake Forest, IL) with Bovine Serum Albumin (ICPbio LTD., Auckland, 
New Zealand).  Total ova, viable embryos, unfertilized ova, and degenerate embryos 
were recorded.  The number of viable embryos was determined using IETS embryo 
grading guidelines, and only embryos that were considered to be grades 1 or 2 were 
counted as viable embryos.   
 Treatment and stimulation cycle effects for the total ova, viable embryos, 
unfertilized ova, degenerate embryos, the proportion of viable embryos to total ova, and 
the transformed (Arc Sin of the square root) portion of viable embryos to total ova were 
analyzed by the GLM procedure of SAS 9.2 (SAS; Cary, NC, USA).  This study was a 
Latin square design.  Possible sources of variation for this study would include: 
treatment, cycle, and donor. 
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Results 
 The mean number of total ova, viable embryos, degenerate embryos, and 
unfertilized ova did not differ significantly between the treatment groups (Table 1).  The 
proportion of viable embryos to total ova collected also did not differ significantly 
between the treatment groups (Table 2).  This suggests that the use of Pluset
®
 in the 
superstimulation protocol for donors was neither beneficial nor detrimental to embryo 
production.   
 
Discussion 
 The substitution of Pluset
®
 for Folltropin
®
 in the last three injections of the 
superovulation protocol was intended to increase embryo production.  By administering 
Pluset
®
 towards the end of the superovulation protocol, which has a higher LH content 
than Folltropin
®
, we hypothesized the increased LH content would facilitate follicular 
growth as the follicles switched from an FSH-dependency to an LH-dependency (Mihm 
and Bleach, 2003).  Also, by only administering Pluset
®
 at the end of the protocol we 
hypothesized the increased LH content would not have a negative effect on the 
percentage of viable embryos that others have reported (reviewed by Mapletoft et al., 
2002).  In the present study, there were no significant differences in the mean number of 
total ova, viable embryos, unfertilized ova, and degenerate embryos between treatment 
groups.  In previous studies, the mean number of total ova collected was significantly 
higher for females treated with only Pluset
®
 compared to mean number of the total ova 
collected for females treated with only Folltropin
®
 (Kelly et al., 1995, Kelly et al., 1997).   
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Table 1.  Mean (±SE) number of total ova, viable embryos, degenerate embryos, and 
unfertilized ova by treatment
a 
 
Treatment (n) Total Ova Viable 
Embryos 
Degenerate 
Embryos 
Unfertilized 
Ova 
      
Folltropin
®
 12 17.42 ± 2.40 9.33 ± 2.07 4.92 ± 1.37 3.17 ± 1.11 
Folltropin
®
+ 
Pluset
®
 
12 12.75 ± 2.56 6.58 ± 1.69 4.42 ± 1.23 1.75 ± 0.76 
 
    a
Means within a column do not differ (P > 0.10). 
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Table 2.  Mean (±SE) number of proportion of viable embryos to total ova and the 
transformed proportion by treatment
a 
 
Treatment (n) Viable/Total Ova Transformed Proportion 
 
   
  Folltropin
®
 12 0.49 ± 0.10 0.76 ±0.13 
  Folltropin
®
+ Pluset
®
 12 0.48 ± 0.08 0.82 ±0.09 
                 a
Means within a column do not differ (P > 0.10). 
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 More importantly, there was not a significant difference in the proportion of 
viable embryos to total ova between the Folltropin
®
 (0.49) and Folltropin
®
 + Pluset
®
 
(0.48) treatment groups and may be attributed to administering the Pluset
®
 at the end of 
the stimulatory protocol.  Studies that used Pluset
®
 throughout the entire stimulation 
protocol reported a decrease in the percentage of viable embryos.  A study with 
crossbred beef heifers compared an eight injection Folltropin
®
 protocol and a ten 
injection Pluset
®
 protocol and reported a higher number of ovulations for the Pluset
®
 
group, but a lower proportion of viable embryos to total ova (Kelly et al., 1997).  The 
aforementioned study only used a prostaglandin F2α analogue (Estrumate) to synchronize 
estrus and during the superstimulation protocol (prostaglandin is not the preferred 
treatment for synchronizing follicular waves); unlike the present study which included 
steroids (E2 and P4) to synchronize follicular waves during the superstimulation 
protocol.  It appears that using Pluset
®
 for the last three injections in the present study 
did not have any detrimental effects on embryo production.  Since no significant 
difference between treatment groups was observed for the percentage of viable embryos 
in this study, we infer that the incidence of premature oocyte maturation or early 
ovulation, reported in other studies (Dieleman et al., 1983, Kruip et al., 1983, Hyttel et 
al., 1991), was not sufficient to cause an increase in unfertilized ova or a decrease in the 
percentage of viable embryos. 
 In this study, a minimum interval of 60 d occurred between stimulated 
cycles.fferences in embryo production were observed due to stimulated cycle between 
donors(first or second stimulated cycle).  Previous studies have reported conflicting 
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results on ovarian responsiveness after repeated superovulatory cycles.  Some have 
indicated a decrease in response after repeated superovulation, while others have 
reported no difference in response between repeated stimulated cycles (reviewed by Kafi 
and McGowan, 1997).  In a study with records from a commercial embryo transfer 
company, a decrease in the number of transferable embryos was observed when donor 
cows were stimulated for multiple cycles (Donaldson and Perry, 1983).  The authors 
attribute this decline in embryo production to depletion in the pool of primary follicles 
due to repeated superovulation, or a possible immune response to the FSH-P.  Another 
study using virgin heifers also reported a decrease in embryo production after repeated 
superovulation (Dorn et al., 1991).  In an older study, no difference in the number of 
transferable embryos was observed when donors were superovulated three times with at 
least 60 days between stimulated cycles (Nelson et al., 1979).   
 The results of this study indicate that Pluset
®
 (with a higher LH content 
compared to Folltropin
®
) can be administered at the end of the gonadotropin stimulation 
in a superovulation protocol and not be detrimental to embryo production.  The use of 
Pluset
®
 at the end of the protocol did not increase unfertilized ova or decrease the 
proportion of viable embryos/total ova as has been reported in prior studies where 
Pluset
®
 was used as the only gonadotropin for the superovulation protocol.  However, 
there was no significant difference between treatment groups in this study; therefore, 
endogenous levels of LH during the stimulated cycle may be sufficient to maintain 
follicular growth after dominant follicles switch to LH-dependency as reported in prior 
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studies using recombinant FSH (Looney et al., 1988) and FSH preparations with varying 
amounts of LH (Mapletoft et al., 2002). 
 
Implications 
 The administration of Pluset
®
 in lieu of Folltropin
®
 for the last three injections in 
a superovulation protocol was not detrimental to embryo production in Beefmaster cows.  
There was no significant difference between treatment groups on total ova, viable 
embryos, unfertilized ova, degenerate embryos, or the proportion of viable embryos/total 
ova.  These results indicate further research could be conducted using a protocol similar 
to this one to determine if embryo production could be increased when compared to a 
Folltropin
®
-only protocol.  Perhaps with the use of varying the doses of Pluset
®
, a dose-
dependent effect on embryo production could be detected, and an optimal dose of 
Pluset
®
 could be determined.  Only one cumulative dose of 120 IU of FSH and 120 IU 
of LH was used in this study.  Also, research comparing the administration of four 
injections of Pluset
®
 instead of the three injections in this protocol may detect a 
difference on embryo production between treatment groups.  The results from this study 
and possible future research could indicate another stimulation protocol that could be 
used successfully to stimulate donor cows and increase embryo production.  This could 
be important to the commercial ET industry because it would give practitioners another 
option to stimulate donors.  Especially for those practitioners who deal mostly with Bos 
indicus-influenced breeds. 
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CHAPTER III 
ESTRUS SYNCHRONIZATION OF BEEF COW RECIPIENTS USING eCG 
 
Introduction 
 Most costs associated with embryo transfer relate to the maintenance of recipient 
females.  Increasing pregnancy rates after embryo transfer will ultimately decrease the 
number of days recipients are open during the breeding season, and will also help to 
reduce the costs incurred to maintain open recipients.  A more cost effective recipient 
program could be implemented by reducing recipient-associated costs. 
 Administration of eCG has been shown to increase CL area and plasma 
progesterone concentrations during the luteal phase in cattle (reviewed by Baruselli et 
al., 2010).  Baruselli et al. (2010) also indicate that conception rates were higher in Bos 
indicus cows with higher plasma progesterone levels when compared to cows with lower 
plasma progesterone levels.  Pregnancy rates are improved in cows with lower body 
condition scores that are administered eCG during estrus synchronization and submitted 
to FTAI (Small et al., 2009).   
 The objective of this study was to evaluate the effect the addition of eCG to an 
estrus synchronization protocol would have on pregnancy rates after embryo transfer in 
recipients.  It was hypothesized that pregnancy rate would increase for recipients that 
were administered eCG. This study was conducted using data obtained from a private 
embryo transfer company (OvaGenix, LP, Bryan, TX, USA).  Due to the conditions of 
29 
 
 
the study, only pregnancy rates and mean number of corpora lutea were reported and no 
statistical analysis was conducted.       
 
Materials and Methods 
  The data from this study was obtained from embryo collection records of work 
performed by a private embryo transfer company, OvaGenix, LP.     
 The objective of this study was to quantify the effect of addition of eCG to a 
synchronization protocol on pregnancy rate in recipient beef cows.  Both the control/no 
eCG (Figure 3) and treatment/eCG groups of multiparous Beefmaster cows were 
synchronized with a common estrus synchronization protocol.  Both groups of recipients 
were administered a CIDR
®
 (Pfizer Animal Health, Kalamazoo, MI, USA) and an 
injection (2 mL, im), containing 25 mg/mL of progesterone and 1.25 mg/mL of estradiol 
(Med Shop Total Care Pharmacy, Inc., Longview, TX, USA), on day 0.  On day 7, the 
CIDR
®
 was removed, and a 2 mL intramuscular injection of Ciclase
®
 (Syntex S.A., 
Buenos Aires, Argentina), a prostaglandin (PGF2α) analogue containing 250 µg/mL of 
cloprostenol, was administered.  An injection (1 mL, im) of estradiol-17β (1 mg/mL 
estradiol-17β; Med Shop Total Care Pharmacy, Inc., Longview, TX, USA) was 
administered on day 8.  The treatment group (Figure 4) was administered 400 IU of eCG 
(Folligon
®
; Intervet Canada Corp., Kirkland, Quebec, Canada; or Novormon 5000; 
Syntex S.A., Buenos Aires, Argentina) on day 5 (CIDR insertion=day 0), and the control 
group did not receive an injection of eCG.   
 
30 
 
 
 
 
 
 
 
Figure 3. Synchronization protocol without eCG. 
 
 
 
 
 
 
 
 
Figure 4. Synchronization protocol with eCG.  
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 Seven days after estrus, if the recipient had an acceptable corpus luteum, an 
embryo (frozen-direct transfer method) was transferred into the uterine horn ipsilateral to 
the CL.  A CL was deemed acceptable for embryo transfer if it was at least 10 mm in 
diameter (Looney et al., 2006).  The embryos for ET company, C, were cryopreserved 
using the direct transfer method described by Pryor et al. (2011).  Embryos were 
equilibrated in 1.5 M ethylene glycol (Vigro Freeze medium without sucrose, Bioniche) 
for a minimum of five minutes, loaded into 0.25 mL sterile straws, and seeded at – 6 °C 
in the cryochamber.  Each loaded straw consisted of three media columns and two air 
columns with one embryo in the middle media column.  The embryos were frozen using 
a freeze control CL5500 unit (Biogenics, Napa, CA, USA) at the rate of – 5 °C/min from 
– 6 °C to – 32 °C.  Once – 32 °C was reached, the straws were then plunged into LN2 
and placed into canes for storage in LN2 tanks.  The frozen-direct transfer embryos were 
thawed for 5-7 seconds at room temperature and then immersed in a 30 °C water bath for 
10 seconds.  Once thawed, the straw was dried off, the plug removed, and was loaded 
into a chemise covered blue metal tip sheath which then covered the ¼ cc Cassou gun.  
The embryo was then transferred nonsurgically into the recipient.  The Cassou gun was 
inserted through the vagina of a recipient with an acceptable CL, and then passed 
through the cervix into the uterine body while the cervix was manipulated rectally to 
allow the passage of the gun through the cervical rings.  The gun was then advanced 
forward past the uterine bifurcation and into uterine horn ipsilateral to the CL where the 
embryo was then expelled.     
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 Data collected for each transfer included the following: treatment (control or 
eCG), embryo breed, embryo stage and grade, number and location of CL(s), embryo 
transfer company responsible for freezing the direct-transfer embryo, and the resulting 
pregnancy status.  Pregnancy rate was reported for both the no eCG and eCG groups, ET 
company responsible for freezing the embryo, embryo stage, embryo grade, and total CL 
number.  Statistical analysis could not be performed because both groups were not 
synchronized for the same transfer date, and the study was conducted over three years 
with a one year lapse occurring between both groups. 
 
Results  
 Pregnancy rate following transfer of Beefmaster frozen embryos between 
recipients that received eCG and recipients that did not receive eCG is reported in Table 
3.  Pregnancy rate by embryo transfer company responsible for freezing the direct 
transfer embryo is also reported in Table 3, along with the pregnancy rate for various 
embryo stages and grades, and CL numbers.  The mean number of corpora lutea for each 
treatment group can be found in Table 4.  The number of corpora lutea (CL) per 
recipient for both treatment groups ranged from one to two corpora lutea.   
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Table 3. Pregnancy rate reported for treatment, ET company responsible for freezing 
embryo, embryo stage, embryo grade, and total CL number 
 No. of 
Transfers 
No. 
Pregnant 
Percent 
Pregnant 
Treatment    
No eCG 332 149 44.9 
eCG 142 55 38.7 
    
ET company responsible for freezing embryo    
A 201 100 49.8 
B   84   45   53.6 
C 189 59 31.2 
    
Embryo stage    
4-compact morula 123 43 35.0 
5-early blastocyst 114 50 43.9 
6-blastocyst 26 6 23.1 
    
Embryo grade    
1 188 66 35.1 
2 
 
Total CL number 
82 37 45.1 
1 464 202 43.5 
2 10 2 20.0 
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Table 4. Mean total number of corpora lutea for recipients that did not receive eCG and 
recipients that did receive eCG 
 
Treatment (n) CL number  Min CL Max CL 
     
No eCG  332 1.003
 
1.00 2.00 
eCG 142
 
1.063
 
1.00 2.00 
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Discussion 
 The addition of eCG to the recipient synchronization protocol was intended to 
increase pregnancy rate.  Published studies have shown an increase in pregnancy rate 
with the addition of eCG to the synchronization protocol (Nasser et al., 2004, Small et 
al., 2009, Baruselli et al., 2010).  In these studies, eCG benefitted pregnancy rate the 
most in Bos indicus influenced recipients and recipients with lower body condition 
scores. 
 Overall the addition of eCG to the synchronization protocol resulted in a lower 
pregnancy rate compared to the pregnancy rate of the synchronization protocol without 
eCG; however, under the conditions of this study these pregnancy rates cannot be 
statistically compared to each other.  Other factors that can affect pregnancy rate such as 
nutrition and weather conditions were not accounted for in this study.  Since each of the 
transfer dates did not have groups of recipients that were synchronized with and without 
eCG, these factors could have had an effect on pregnancy rate.  
Various pregnancy rates were observed among the different ET companies 
responsible for freezing the direct transfer embryos.  Benyei et al. (2006) reported a 
significant difference in pregnancy rate among ET companies used in their experiment, 
and they attribute this difference to the subjective embryo evaluation among the staff of 
the ET companies.  The majority of embryos, in the present study, that were transferred 
on each of the transfer dates came from a single company, meaning a mixture of direct 
transfer frozen embryos from all three companies were not transferred on the same date.  
The variance in pregnancy rates between the ET companies could be a result of the time 
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of the year the embryos were transferred, or the embryo stage and grade of the embryos 
transferred.  The recipients would have been under different weather conditions, and 
possibly different nutrition, depending on the time of year the embryos were transferred, 
leading to differences in pregnancy rates regardless of the ET company responsible for 
freezing those embryos.  In Brazil, a higher pregnancy rate was reported for embryos 
transferred during the wet season than for embryos transferred during the dry season 
(Benyei et al., 2006).  The authors associate the difference in pregnancy rate between 
seasons with the better nutrition that was available to the recipients during the wet 
seasons.  Differences in the media used between the different ET companies and 
freezing protocols could also be a source of variation, and this could explain the 
variances observed in pregnancy rates between the companies.  The cryoprotectant used 
for freezing direct transfer embryos is 1.5 M ethylene glycol.  Bovine embryos have a 
higher degree of permeability to ethylene glycol than glycerol (Voelkel and Hu, 1992).  
The authors report embryos exposed to ethylene glycol show less volume shrinkage 
(which can be detrimental to the embryo) than embryos exposed to glycerol, and 
embryos exposed to ethylene glycol return to their original volume more quickly than 
the embryos exposed to glycerol.  Voelkel and Hu (1992) observed no difference in 
pregnancy rates between embryos frozen in ethylene glycol and embryos frozen in 
glycerol.  The authors contend the increased permeability bovine embryos have to 
ethylene glycol allows for the direct rehydration of the embryos in the uterus after 
transfer; unlike embryos frozen in glycerol, in which the embryos are rehydrated step-
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wise using solutions with decreasing concentrations of glycerol or non-permeable 
osmotic buffers like sucrose.   
In the present study, various pregnancy rates were observed among embryo 
stages and between grades.  A study, using Angus recipients, did not report any 
significant differences in pregnancy rates among embryo stages 4, 5, and 6 (Spell et al., 
2001).  However, other studies (Martinez et al., 2002, Dochi et al., 1998) have reported 
higher pregnancy rates for compact morula and early blastocyst stages compared to 
pregnancy rates for blastocyst stage direct transfer embryos.  The authors suggest the 
lower pregnancy rate observed for blastocysts could be attributed to the increased water 
content found in the blastocoel cavity which may increase the chance of ice crystal 
formation (which can damage the embryo) during the freezing process.  Another study 
(Dochi et al., 1995) reported lower pregnancy rates for morula direct transfer embryos 
when compared to blastocysts, but a low number of embryos were transferred in this 
study.  In a retrospective study with embryos frozen in glycerol, higher pregnancy rates 
were correlated with higher embryo quality grades (Hasler, 2001).  However, another 
study reported no differences in pregnancy rates among embryo quality grades 1 and 2 
of glycerol frozen embryos (Spell et al., 2001).  In the present study the pregnancy rate 
for grade 1 embryos was numerically 10% lower than the pregnancy rate for grade 2 
embryos; however, due to the limitations of this study these pregnancy rates cannot be 
statistically compared to each other. 
An increase in the number of corpora lutea would be expected for the group of 
recipients that were administered eCG as part of their synchronization protocol.  In this 
38 
 
 
study, the reported mean number of corpora lutea was slightly higher for the eCG-treated 
group of recipients, but no statistical analysis comparing the treatment groups was 
performed.  A previous study using eCG reported a mean CL number of 1.37 for a group 
of recipients synchronized using the same protocol used in this study (Nasser et al., 
2004).  Since, the mean number of CL’s for this study was lower than the mean number 
of CL’s reported in the Nasser et al. (2004) study, it might help to explain why no 
improvement in pregnancy rates was found for the eCG treated recipients in this study.  
Only 10 recipients had 2 CL’s in this study, 1 recipient in the group not treated with eCG 
and 9 recipients in the group treated with eCG.  The pregnancy rate was lower for 
recipients with 2 CL’s, but under the conditions of this study the pregnancy rate between 
the two groups (1 CL or 2 CL) cannot be compared.     
The results for this study do not indicate the addition of eCG to a synchronization 
protocol for embryo transfer to be beneficial; however, a controlled study is warranted to 
further investigate the potential effect of eCG on pregnancy rate in recipients.   
 
Implications 
The addition of eCG to the synchronization protocol for recipients for embryo 
transfer did not increase pregnancy rate overall.  However, in this study recipients were 
only synchronized with one protocol for each set (date) of transfers, instead of 
synchronizing recipients with each protocol for each set of transfers.  This is why no 
statistical analysis was performed on the data for this study.  Weather conditions and 
nutrition have been reported to affect pregnancy rate in Bos-indicus influenced females 
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(Randel, 1994, Benyei et al., 2006).  Since recipients were not synchronized as a group 
with the addition of eCG and a group without eCG during each set of transfers, these 
effects cannot be ruled out.  Future research using both protocols concurrently for 
multiple sets of transfers would allow for valid conclusions to be made.  Also, analyzing 
body condition score (BCS) compared to pregnancy rate for the treatment groups (eCG 
and no eCG) would be important since previous data indicate eCG is beneficial to 
pregnancy rate in lower BCS females (Small et al., 2009, Sales et al., 2011).  Observing 
the number of recipients that are rejected, due to an inadequate CL or absence of a CL, 
for each protocol would also be beneficial.  If a fewer number, or percentage, of 
recipients were found to be rejected for recipients treated with eCG this could indicate a 
benefit for the use of eCG; even if the pregnancy rates did not differ between recipients 
who received eCG and recipients that did not receive eCG.  Rejecting fewer recipients 
would result in more embryos transferred and more pregnancies, even if pregnancy rate 
did not differ.     
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CHAPTER IV 
CONCLUSIONS 
 
 The results from the first retrospective study indicate that Pluset
®
 can be used as  
the last three gonadotropin injections during a stimulation protocol to superovulate 
Beefmaster donor cows without having a significant effect on embryo production when 
compared to a stimulation protocol using only Folltropin
®
.  Although the mean number 
of viable embryos tended to be lower for donors who received Pluset
®
 when compared 
to donors who received only Folltropin
®
, this difference was not significant.  More 
importantly, the proportion of viable embryos to total ova was approximately equal for 
the stimulation protocol using only Folltropin
®
 and the stimulation protocol using both 
Folltropin
®
 and Pluset
®
.  These results differ from other studies which report a decrease 
in the proportion of viable embryos to total ova typically observed when gonadotropin 
preparations containing a higher LH content are used as the sole hormone preparation 
during the stimulation protocol.  Further research using more than one hormone 
preparation during the stimulation protocol to improve embryo production is warranted. 
 The results from the second retrospective study do not indicate that the addition 
of eCG to an estrus synchronization protocol for beef recipients in an embryo transfer 
program is beneficial.  However, a control group and treatment group were not set up for 
each set of transfers; therefore, other factors such as environmental factors could have 
masked any effects that the addition of eCG could have had.  More research is warranted 
in this case, so a control group and treatment group of recipients can be set up for the 
41 
 
 
same set of transfers.  It would also be beneficial to record the number of recipients that 
were synchronized but rejected at the time of embryo transfer due to an inadequate CL 
or absence of a CL.  Further research may show that although eCG may not increase 
pregnancy rate, it may decrease the percentage of recipients rejected which would 
increase the number of embryos transferred and ultimately result in more pregnancies. 
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